Authors


Gregory Pontone, MD

Latest:

Implications of Impulse Control Disorder in Parkinson Disease

The challenges of recognizing behaviors such as hypersexuality, gambling, and excessive buying in Parkinson disease are discussed, as are ways to address them while still managing the underlying condition.


Gregory T. Eells, PhD

Latest:

Working Within a Campus Health Service: A Challenge With Many Rewards

Psychiatrists can provide significant support and insight to patients who are now coming to campus with a wide array of mental health challenges.


Gregory Tau, MD, PhD

Latest:

Effects of Adolescent Marijuana Use on Cognition

In this brief video, an expert summarizes the effects of marijuana use on the teenage brain, as well as new strategies to discuss the consequences of drug use with adolescents.


Greta L. Doctoroff, PhD

Latest:

Infant Psychiatry

Infant, or developmental, psychiatry is a subspecialty of child and adolescent psychiatry that focuses on the promotion of mental health in infants, toddlers, preschoolers, and their families through the consultation, assessment, and treatment of clinical problems.


Gretchen J. Diefenbach, PhD

Latest:

Does TMS Hold Promise for Generalized Anxiety Disorder?

Available data suggest that transcranial magnetic stimulation holds promise as a treatment for GAD. Here: a look at what we know.


Gretchen N. Neigh, PhD

Latest:

Biological Consequences and Transgenerational Impact of Violence and Abuse

Every year, more than 1 million children are exposed to sexual or physical abuse or neglect in the US. The research summarized here clearly demonstrates that exposure to stress before adulthood can result in persistent effects on both mental and physical health.


Group for the Advancement of Psychiatry

Latest:

Can Psychiatry Sustain Connections While Hosting Sustainable Conferences?

Sustainability is more than just cutting carbon emissions. It means creating a system where all of us can thrive—not just survive.


Guido K. W. Frank, MD

Latest:

Novel Research in the Neuropsychiatry of Anorexia Nervosa

Research is now making progress in understanding what happens before and during the illness and how this behavior can be explained.


Guitelle St. Victor, MD

Latest:

Speaking Up: Sexual Harassment in the Medical Setting

Here: a review of the definition of sexual harassment, its prevalence among physicians and medical students, its potential impact on physicians and trainees, and guidance about its management.


Gunnar Morken, MD

Latest:

Seasonal Variation of Violence

The author examines how temperature and length of day can affect mood and behavior, both in a general population and a group of inpatients. In both groups, there were two peaks of violent behavior, one in May-June and one in October-November, which correspond with the equinoxes. Is it possible to track violent behavior in various geographical areas depending upon weather and length of day?


Gunvant K. Thaker, MD

Latest:

Introduction: Schizophrenia Spectrum Disorders

Clinicians have long recognized that many of the psychiatric disorders lack clear boundaries, and that there is a substantial overlap in phenomenology and etiopathophysiology of various disorders.


Guochuan E. Tsai, MD, PhD

Latest:

A New Class of Antipsychotic Drugs

The development of new, more effective antipsychotics with fewer adverse effects (eg, extrapyramidal symptoms, tardive dyskin­esia, metabolic syndrome) is paramount.


Guowei Li

Latest:

What Is the Role of Vitamin D in Depression?

Vitamin D has been hailed as the “sunshine” vitamin with many therapeutic attributes. The authors explore the association between vitamin D deficiency and increased risk of depression.


Gurneet Thiara, MD

Latest:

Psychiatric Care of Patients With Hepatitis C: A Clinical Update

The prevalence of chronic hepatitis C virus infection is among the highest in patients with severe underlying mental illness. Here: clinical information on the interface of HCV infection and psychiatric disorders.


Gustavo Goldstein, MD

Latest:

DSM-5: What It Will Mean to Your Practice

Undoubtedly there will be problems with some of the additions to DSM-5, with some of the combinations, with some of the new nomenclature, and with some of the new criteria sets. But practitioners will find most of DSM-5 to be well considered and well written. It is unfortunate, however, that much of its nomenclature is out of sync with the rest of medicine.


Gustavo H. Vázquez, MD, PhD

Latest:

“Switching” of Mood From Depression to Mania With Antidepressants

Mood switching is not uncommon and it is much more prevalent in depressed juveniles than in depressed adults, and there is a large apparent excess of antidepressant-associated switching over reported spontaneous diagnostic changes to bipolar disorder. Details here.


Guy G. Potter, PhD

Latest:

7 Components of Depression Evaluation

The co-occurrence of depression and cognitive impairment doubles every 5 years after the age of 70. Here we present a list of elements in a comprehensive and extended evaluation of depression in the elderly.


Guy Rordorf, MD

Latest:

Hemicraniectomy for Massive Basal Ganglia Hemorrhage

intracerebral hemorrhage, hemicraniectomy, stroke, neurosurgery, traumatic brain injury


Gwen Wimby, RN, MSA

Latest:

Reducing Risk Associated With Seclusion and Restraint

This article briefly reviews the federal standards regarding S/R and methods of reducing the risk associated with their use. CMS standards that went into effect February 6, 2007, will be emphasized; however, some of these standards vary from JCAHO standards.



H. Blair Simpson, MD, PhD

Latest:

Using the Internet to Increase Access to Evidence-Based Treatment for Obsessive-Compulsive Disorder

Internet-based CBT has shown promise to improve access to therapy for patients with OCD, which is associated with a profoundly diminished quality of life and social isolation.


H. George Nurnberg, MD

Latest:

Options for Management of Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

Among 25 to 30 million Americans in whom depression is diagnosed annually, 18 to 25 million are treated with antidepressants, of which 90% are SSRI or non-selective serotonin reuptake inhibitor (SRI) antidepressants, the most frequently prescribed medications for all outpatients aged 18 to 65 years.



H. Richard Lamb, MD

Latest:

Involuntary Treatment and the Use of Jails to Treat the Mentally Ill

All physicians need to be aware of the medicolegal aspects of practicing medicine, but because emergency psychiatrists must sometimes treat patients against their will or act as consultants to determine capacity, they must be especially vigilant when dealing with the overlap between law and medicine.


H. Steven Moffic, MD

Latest:

Hineni: Looking for the Healers and Healing in Our Presidential Transition

We are always ready for individual patient care. Can we also be ready for social psychiatric care?


H. W. Lebourgeois Iii, MD

Latest:

Malingering: Key Points in Assessment

The assessment of malingering presents a significant challenge for mental health clinicians.


H.A. Abella

Latest:

Pet Technology Sheds Light On Tobacco Dependence

Typical smokers need to have brain nicotine receptors almost completely saturated throughout the day. This need creates an almost uncontrollable urge to keep smoking, commented Nora D. Volkow, MD, director of the National Institute on Drug Abuse (NIDA), addressing a study by NIDA researchers on nicotine addiction.


Hae-Joon Kim

Latest:

Violence in Bipolar Disorder

What is the association between bipolar disorder, trauma, and violence? Here: a guide to assessing violence potential in bipolar patients.


Hagop Akiskal, MD

Latest:

Biomarkers for Mental Disorders: A Field Whose Time Has Come

Biomarkers for mental disorders is a field whose time has come. Optimists will say within a few years, pessimists might say a decade or beyond.


Hal Elliott, MD

Latest:

Premenstrual Dysphoric Disorder: An Update on Diagnosis and Treatment

Premenstrual dysphoric disorder (PMDD) is a distinct cyclical disorder in which women experience distressed mood and behavioral symptoms in the late luteal or premenstrual phase of their menstrual cycle. PMDD is the most extreme or severe form of premenstrual syndrome (PMS).

© 2024 MJH Life Sciences

All rights reserved.